Wave Life Sciences Ltd [WVE] stock prices are up 3.14% to $6.24 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The WVE shares have gain 3.31% over the last week, with a monthly amount drifted -14.99%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Wave Life Sciences Ltd [NASDAQ: WVE] stock has seen the most recent analyst activity on April 29, 2025, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $10. Previously, Wedbush started tracking the stock with Outperform rating on April 08, 2025, and set its price target to $18. On February 25, 2025, Jefferies initiated with a Buy rating and assigned a price target of $26 on the stock. Raymond James upgraded its rating to a Strong Buy but stick to its price target of $22 on October 16, 2024. B. Riley Securities started tracking with a Buy rating for this stock on September 19, 2024, and assigned it a price target of $11. In a note dated September 09, 2024, JP Morgan initiated an Overweight rating and provided a target price of $10 on this stock.
The stock price of Wave Life Sciences Ltd [WVE] has been fluctuating between $4.25 and $16.74 over the past year. Currently, Wall Street analysts expect the stock to reach $22.14 within the next 12 months. Wave Life Sciences Ltd [NASDAQ: WVE] shares were valued at $6.24 at the most recent close of the market. An investor can expect a potential return of 254.81% based on the average WVE price forecast.
Analyzing the WVE fundamentals
The Wave Life Sciences Ltd [NASDAQ:WVE] reported sales of 104.94M for trailing twelve months, representing a drop of -26.82%. Gross Profit Margin for this corporation currently stands at 0.51% with Operating Profit Margin at -1.2%, Pretax Profit Margin comes in at -1.07%, and Net Profit Margin reading is -1.07%. To continue investigating profitability, this company’s Return on Assets is posted at -0.39, Equity is -0.85 and Total Capital is -0.63. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.09 points at the first support level, and at 5.95 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.34, and for the 2nd resistance point, it is at 6.45.
Ratios To Look Out For
It’s worth pointing out that Wave Life Sciences Ltd [NASDAQ:WVE]’s Current Ratio is 2.95. In addition, the Quick Ratio stands at 2.95 and the Cash Ratio stands at 2.78. Considering the valuation of this stock, the price to sales ratio is 9.17, the price to book ratio is 5.60.
Transactions by insiders
Recent insider trading involved HENRY CHRISTIAN O, Director, that happened on Mar 20 ’25 when 10500.0 shares were sold. Director, Christian Henry completed a deal on Mar 20 ’25 to buy 10500.0 shares. Meanwhile, President and CEO BOLNO PAUL sold 0.17 million shares on Mar 07 ’25.
